Literature DB >> 29631184

Modulation of innate and adaptive immunity by P2X ion channels.

Francesco Di Virgilio1, Alba Clara Sarti2, Fabio Grassi3.   

Abstract

Extracellular ATP is a major component of the inflammatory microenvironment where it accumulates following cell and tissue injury but also as a consequence of non-lytic release from activated inflammatory cells. In the inflammatory microenvironment ATP binds and activates nucleotide receptors of the P2Y and P2X subfamilies expressed by immune cells. P2Y receptors are G-protein-coupled, while P2X receptors are cation-selective channels. Changes in the intracellular ion homeostasis triggered by P2X receptor stimulation trigger multiple key responses crucial for initiation, propagation, and resolution of inflammation. In the P2X receptor family, the P2X7 subtype has an important role in the activation of lymphocyte, granulocyte, macrophage and dendritic cell responses. Although clinical studies have been so far rather inconclusive, it is believed that P2X7 receptor targeting might offer novel perspectives for anti-inflammatory therapy.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29631184     DOI: 10.1016/j.coi.2018.03.026

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  19 in total

Review 1.  Danger signals from mitochondrial DAMPS in trauma and post-injury sepsis.

Authors:  C J Hauser; L E Otterbein
Journal:  Eur J Trauma Emerg Surg       Date:  2018-05-24       Impact factor: 3.693

2.  Ca2+ flux through splice variants of the ATP-gated ionotropic receptor P2X7 is regulated by its cytoplasmic N terminus.

Authors:  Xin Liang; Damien S K Samways; Jane Cox; Terrance M Egan
Journal:  J Biol Chem       Date:  2019-06-27       Impact factor: 5.157

3.  ATP-Gated P2X7 Receptors Require Chloride Channels To Promote Inflammation in Human Macrophages.

Authors:  Laura Janks; Randy S Sprague; Terrance M Egan
Journal:  J Immunol       Date:  2018-12-31       Impact factor: 5.422

Review 4.  Regulation of immune responses by tuft cells.

Authors:  Christoph Schneider; Claire E O'Leary; Richard M Locksley
Journal:  Nat Rev Immunol       Date:  2019-09       Impact factor: 53.106

Review 5.  P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance.

Authors:  Roberto Coccurello; Cinzia Volonté
Journal:  Front Endocrinol (Lausanne)       Date:  2020-05-12       Impact factor: 5.555

6.  The P2X7 Receptor Is Shed Into Circulation: Correlation With C-Reactive Protein Levels.

Authors:  Anna Lisa Giuliani; Merhej Berchan; Juana M Sanz; Angelina Passaro; Stefano Pizzicotti; Valentina Vultaggio-Poma; Alba Clara Sarti; Francesco Di Virgilio
Journal:  Front Immunol       Date:  2019-04-12       Impact factor: 7.561

Review 7.  P2X7 Interactions and Signaling - Making Head or Tail of It.

Authors:  Robin Kopp; Anna Krautloher; Antonio Ramírez-Fernández; Annette Nicke
Journal:  Front Mol Neurosci       Date:  2019-08-07       Impact factor: 5.639

Review 8.  Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity.

Authors:  Juliana Hofstätter Azambuja; Nils Ludwig; Elizandra Braganhol; Theresa L Whiteside
Journal:  Int J Mol Sci       Date:  2019-11-14       Impact factor: 5.923

9.  New Insights Into Permeation of Large Cations Through ATP-Gated P2X Receptors.

Authors:  Laurie Peverini; Juline Beudez; Kate Dunning; Thierry Chataigneau; Thomas Grutter
Journal:  Front Mol Neurosci       Date:  2018-07-31       Impact factor: 5.639

10.  Deviant reporter expression and P2X4 passenger gene overexpression in the soluble EGFP BAC transgenic P2X7 reporter mouse model.

Authors:  Antonio Ramírez-Fernández; Lidia Urbina-Treviño; Giorgia Conte; Mariana Alves; Björn Rissiek; Anna Durner; Nicolas Scalbert; Jiong Zhang; Tim Magnus; Friedrich Koch-Nolte; Nikolaus Plesnila; Jan M Deussing; Tobias Engel; Robin Kopp; Annette Nicke
Journal:  Sci Rep       Date:  2020-11-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.